MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

The model, 34, and the comedian, 37, who are parents to daughter Elsie, two, became engaged when he popped the question in ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...

Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...

Discover why DexCom (DXCM) could rebound in 2025. Explore buyback plans, growth potential, and investment insights in the ...

The Global Sensor Patch Market is projected to reach USD 96.85 Billion by 2035, growing at a CAGR of 38.95%. Discover the ...

DexCom, Inc. (NASDAQ:DXCM) is one of the stocks on Jim Cramer’s radar recently. A caller asked if they should buy, sell, or hold the stock during the lightning round. In response, Cramer said: “You ...

Abstract: This review paper explores the most common technologies of vector magnetic field sensors. Specifically, the AMR, GMR, TMR, GMI, Hall, Fluxgate, Search Coil and SQUID sensors are considered.

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...